Answers are grounded in this paper and cite their sources.
The Wilms tumor 1 (WT1) gene, located at locus 11p13, is a tumor suppressor gene that encodes a zinc-finger transcription factor.1,2 The presence of WT1 gene mutation (mWT1) among adult patients with acute myeloid leukemia (AML) has been associated with poor prognoses.1,3 Outcomes of allogeneic stem cell transplantation (alloSCT) in patients with mWT1 AML have been explored in only a few studies limited by small sample size and inclusion of other gene mutations.[4][5][6][7] The goal of this study was to determine factors affecting post-alloSCT survival in patients with mWT1 myeloid neoplasms.We retrospectively reviewed patients with mWT1 myeloid neoplasms, as defined by the World Health Organization.8 The study was approved by the Mayo Clinic institutional review board and conducted in accordance with the Declaration of Helsinki.Patients with ≥2 WT1 mutations were deemed to have multihit WT1 (mhWT1) mutations.Given the limited sample size, we decided a priori upon variables deemed important from previous transplantation studies [9][10][11][12][13][14] to be included in stepwise regression analysis and arrived at the final multivariate model.Please refer to supplemental Methods for a detailed description of methods.A total of 6887 patients were tested, and 75 (1.1%)patients were found to harbor a WT1 mutation.Fiftysix (74.7%) had AML, 7 (9.3%) had myelodysplastic syndrome (MDS), 6 (8%) had mixed phenotypic acute leukemia (MPAL), and 6 (8%) patients had other myeloid neoplasms.Median age at diagnosis was 60 years (interquartile range [IQR], 42-67 years).Among patients with MDS, 4 (57.1%) had MDS with increased blasts (MDS-IB): 3 (42.9%)had MDS-IB2 and 1 (14.3%) had MDS-IB1.Median overall survival (OS) for the entire cohort was 1.9 years (95% confidence interval [CI], 1.45-2.42).
No takes yet. Share an insight, caveat, or question.
Baranwal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: